908 Devices Inc.

MASS Healthcare Medical Devices

In the quarter to June 2026, revenue grew 23.3%, EPS grew 13.5% and free cash flow grew 151.0%, each against the same quarter a year earlier.

11.33 0.56 −4.71%
Market cap
$491.5M
P/E
0.0×
Fwd P/E
−13.3×
Dividend yield
—
F-score
5/9
Altman Z
1.10
Beneish M
−2.52
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
5 4 5 3

+8 more TTM periods

ROE
(25.15%) (24.57%) 15.09% (3.09%)
ROA
(17.81%) (18.85%) 11.15% (2.24%)
ROIC
(96.41%) (115.03%) (80.18%) (152.75%)
Return on Tangible Assets
(39.74%) (33.87%) 16.99% (3.84%)
Average Days of Receivables
70.25 62.30 73.57 75.53
Free Cash Flow per Share
0.02 (0.23) (0.69) (0.79)
Free Cash Flow
0.62 (8.30) (24.64) (28.40)
Capital Expenditures
(0.88) (0.84) (0.95) (1.15)
Other line items
Cash ROIC
0.27% (3.38%) (9.60%) (11.44%)
Accounts Receivable Turnover
6.79 6.88 5.57 3.84
Accounts Payable Turnover
9.25 8.96 18.80 14.69
Inventory Turnover
1.95 2.16 2.33 1.64
Average Days of Payables
34.00 31.44 20.84 24.29
Days of Inventory on Hand
180.23 172.37 170.71 205.53
Tax Rate
0.00 0.00 (0.01) 0.00
Research and Development Expense of Revenue
23.69% 26.33% 27.72% 30.04%
Selling, General and Administrative Expense of Revenue
64.07% 66.09% 68.56% 75.57%
Share Based Compensation of Revenue
16.20% 17.09% 17.52% 18.63%
Operating CF/Net income
(0.04) 0.21 (1.22) 6.60
Depreciation/Fixed assets
1.02 0.97 0.90 3.47
Capex/Depreciation
(0.19) (0.21) (0.25) (0.08)
Revenue per Share
1.61 1.57 1.57 1.47
Operating CF per Share
0.04 (0.20) (0.66) (0.75)
Capex per Share
(0.02) (0.02) (0.03) (0.03)
Capex to Sales
0.01 0.01 0.02 0.02

Fold the line items

Columns are period end dates